Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection.

Crandall KA, Kelsey CR, Imamichi H, Lane HC, Salzman NP.

Mol Biol Evol. 1999 Mar;16(3):372-82.

PMID:
10331263
2.

Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.

Zhang YM, Imamichi H, Imamichi T, Lane HC, Falloon J, Vasudevachari MB, Salzman NP.

J Virol. 1997 Sep;71(9):6662-70.

3.

Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection.

Vasudevachari MB, Zhang YM, Imamichi H, Imamichi T, Falloon J, Salzman NP.

Antimicrob Agents Chemother. 1996 Nov;40(11):2535-41.

4.

Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial.

Kovacs JA, Bechtel C, Davey RT Jr, Falloon J, Polis MA, Walker RE, Metcalf JA, Davey V, Piscitelli SC, Baseler M, Dewar R, Salzman NP, Masur H, Lane HC.

J Infect Dis. 1996 Apr;173(4):840-8.

PMID:
8603961
5.

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, et al.

N Engl J Med. 1995 Mar 2;332(9):567-75.

6.

Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma.

Dewar RL, Highbarger HC, Sarmiento MD, Todd JA, Vasudevachari MB, Davey RT Jr, Kovacs JA, Salzman NP, Lane HC, Urdea MS.

J Infect Dis. 1994 Nov;170(5):1172-9.

PMID:
7963710
7.

An internally controlled virion PCR for the measurement of HIV-1 RNA in plasma.

Natarajan V, Plishka RJ, Scott EW, Lane HC, Salzman NP.

PCR Methods Appl. 1994 Jun;3(6):346-50.

9.

Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.

Natarajan V, Radjendirane V, Salzman NP.

Virology. 1993 Sep;196(1):122-9.

PMID:
8356789
10.

Detection of HIV in bone allografts prepared from AIDS autopsy tissue.

Salzman NP, Psallidopoulos M, Prewett AB, O'Leary R.

Clin Orthop Relat Res. 1993 Jul;(292):384-90.

PMID:
8519136
11.

Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assay.

Vasudevachari MB, Salzman NP, Woll DR, Mast C, Uffelman KW, Toedter G, Hoefheinz D, Metcalf JA, Lane HC.

J Clin Immunol. 1993 May;13(3):185-92.

PMID:
8100572
12.

Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors.

Vasudevachari MB, Battista C, Lane HC, Psallidopoulos MC, Zhao B, Cook J, Palmer JR, Romero DL, Tarpley WG, Salzman NP.

Virology. 1992 Sep;190(1):269-77.

PMID:
1382341
13.

Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160.

Vasudevachari MB, Uffelman KW, Kovacs J, Yeh CK, Lane HC, Salzman NP.

J Acquir Immune Defic Syndr. 1992;5(8):817-21. Erratum in: J Acquir Immune Defic Syndr 1992;5(11):1179.

PMID:
1517967
14.

Isolation of HIV-1 from plasma of infected individuals: an analysis of experimental conditions affecting successful virus propagation.

Dewar RL, Sarmiento MD, Lawton ES, Clark HM, Kennedy PE, Shah A, Baseler M, Metcalf JA, Lane HC, Salzman NP.

J Acquir Immune Defic Syndr. 1992;5(8):822-8.

PMID:
1355557
15.

Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease.

Schnittman SM, Greenhouse JJ, Psallidopoulos MC, Baseler M, Salzman NP, Fauci AS, Lane HC.

Ann Intern Med. 1990 Sep 15;113(6):438-43.

PMID:
1974752
16.

Suppression of HIV-1 reverse transcriptase activity by mycoplasma contamination of cell cultures.

Vasudevachari MB, Mast TC, Salzman NP.

AIDS Res Hum Retroviruses. 1990 Mar;6(3):411-6.

PMID:
1692726
17.

Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals.

Psallidopoulos MC, Schnittman SM, Thompson LM 3rd, Baseler M, Fauci AS, Lane HC, Salzman NP.

J Virol. 1989 Nov;63(11):4626-31.

18.

Detection of antibodies to human immunodeficiency virus type 1 in whole blood and saliva by using a passive hemagglutination test.

Vasudevachari MB, Uffelman K, Pierce PF, Lane HC, Salzman NP.

J Clin Microbiol. 1989 Oct;27(10):2384-5.

19.

The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4.

Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, Fauci AS.

Science. 1989 Jul 21;245(4915):305-8. Erratum in: Science 1989 Aug 18;245(4919):preceding 694.

PMID:
2665081
20.

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.

Lane HC, Falloon J, Walker RE, Deyton L, Kovacs JA, Masur H, Banks S, Kirk LE, Baseler MW, Salzman NP, et al.

Ann Intern Med. 1989 Jul 1;111(1):41-50. Erratum in: Ann Intern Med 1990 Mar 1;112(5):388.

PMID:
2735626
21.
22.
23.
24.
25.

Cotransfection with adenovirus DNA enhances transcription from linear DNA containing eucaryotic promoters.

Vasudevachari MB, Natarajan V, Salzman NP.

Mol Cell Biol. 1987 Mar;7(3):1063-9.

26.

Mapping 5' termini of JC virus early RNAs.

Kenney S, Natarajan V, Selzer G, Salzman NP.

J Virol. 1986 May;58(2):651-4.

27.

Mapping 5' termini of JC virus late RNA.

Kenney S, Natarajan V, Salzman NP.

J Virol. 1986 Apr;58(1):216-9.

29.

Cis and trans activation of adenovirus IVa2 gene transcription.

Natarajan V, Salzman NP.

Nucleic Acids Res. 1985 Jun 11;13(11):4067-83.

30.
32.

SV40 promoters and their regulation.

Das GC, Niyogi SK, Salzman NP.

Prog Nucleic Acid Res Mol Biol. 1985;32:217-36. Review. No abstract available.

PMID:
3003799
33.

JC virus enhancer-promoter active in human brain cells.

Kenney S, Natarajan V, Strike D, Khoury G, Salzman NP.

Science. 1984 Dec 14;226(4680):1337-9.

PMID:
6095453
34.

Simian virus 40 guanine-cytosine-rich sequences function as independent transcriptional control elements in vitro.

Mishoe H, Brady JN, Radonovich M, Salzman NP.

Mol Cell Biol. 1984 Dec;4(12):2911-20.

35.

Proximal and distal domains that control in vitro transcription of the adenovirus IVa2 gene.

Natarajan V, Madden MJ, Salzman NP.

Proc Natl Acad Sci U S A. 1984 Oct;81(20):6290-4.

36.
37.

Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcription.

Brady J, Radonovich M, Thoren M, Das G, Salzman NP.

Mol Cell Biol. 1984 Jan;4(1):133-41.

38.
39.

Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA.

Brady J, Radonovich M, Vodkin M, Natarajan V, Thoren M, Das G, Janik J, Salzman NP.

Cell. 1982 Dec;31(3 Pt 2):625-33.

PMID:
7159930
40.

Accurate transcription of simian virus 40 chromatin in a HeLa cell extract.

Brady JN, Radonovich M, Salzman NP.

J Virol. 1982 Dec;44(3):772-81.

41.

Interaction between calf thymus RNA polymerase II and singly nicked Simian virus 40 DNA.

Lavialle C, Sekura R, Madden MJ, Salzman NP.

J Biol Chem. 1982 Oct 25;257(20):12458-66. No abstract available.

42.
43.
44.

Stable association of viral protein VP1 with simian virus 40 DNA.

Brady JN, Lavialle CA, Radonovich MF, Salzman NP.

J Virol. 1981 Aug;39(2):432-7.

45.
46.

Evidence for the role of double-helical structures in the maturation of simian virus-40 messenger RNA.

Chiu NH, Bruszewski WB, Salzman NP.

Nucleic Acids Res. 1980 Jan 11;8(1):153-68.

47.

Characterization of the 5'-terminal structure of simian virus 40 early mRNA's.

Thompson JA, Radonovich MF, Salzman NP.

J Virol. 1979 Aug;31(2):437-46.

49.

Regulation of simian virus 40 early and late gene transcription without viral DNA replication.

Birkenmeier EH, Chiu N, Radonovich MF, May E, Salzman NP.

J Virol. 1979 Mar;29(3):983-9.

50.

Selective degradation of newly synthesized nonmessenger simian virus 40 transcripts.

Chiu NH, Radonovich MF, Thoren MM, Salzman NP.

J Virol. 1978 Nov;28(2):590-9.

Supplemental Content

Loading ...
Support Center